Revelation Biosciences
Latest round
- Series A
Last raised
- Jan 2021
Total raised
- $4M
Investors
- 1
About Revelation Biosciences
Revelation Biosciences, Inc.Founded in 2020 in San Diego, US, Revelation Biosciences, Inc. specializes in creating immune-modulating therapies. The company underwent a merger with Petra Acquisition Inc. in December 2021, leading to its forthcoming public listing. The CEO, James Rolke, oversees operations and strategic direction.Revelation Biosciences develops therapeutic solutions to address inflammation-related health issues. Their primary product, Gemini, is an intravenous formulation designed to modulate the innate immune response in patients facing trauma and infection.Revenue for Revelation Biosciences is generated through direct sales of Gemini to healthcare providers, based on B2B agreements with hospitals and clinics. The company is working on new products aimed at further optimizing its therapeutic offerings. Additionally, they seek to broaden their market reach, focusing on North America, Europe, and Asia by the end of 2024.
Who invested in Revelation Biosciences
1 investor across 1 round
See all investors in Revelation Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 5, 2021
Amount
$4M
Investors
Questions about Revelation Biosciences
Who invested in Revelation Biosciences?
Revelation Biosciences has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Revelation Biosciences raised?
Revelation Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Revelation Biosciences last raise money?
Revelation Biosciences's most recent round on record is a Series A, in Jan 2021.
What does Revelation Biosciences do?
Revelation Biosciences is a biotechnology company.
Where is Revelation Biosciences headquartered?
Revelation Biosciences is headquartered in San Diego, US.
Which VCs invest in companies like Revelation Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Revelation Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Revelation Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.